Peripheral IV Cannulation

Vein Selection
SiteNotesPriority
Forearm (cephalic/basilic)Preferred site for ongoing IV access — stable, less painful1st choice
Antecubital fossaLarge, easy to access — use for sampling or short-term; avoid for ongoing access (restricts elbow movement)2nd / last resort ongoing
Dorsum of handPainful, infiltrate easily, fragile veins — elderly/paediatricUse if forearm unavailable
External jugularEmergency access only — requires senior nurse / physicianEmergency
Cannula Gauge Selection
GaugeColourIndication
14GOrangeTrauma, rapid fluid/blood transfusion
16GGreyBlood transfusion, theatre, surgery
18GGreenStandard adult — IV fluids, antibiotics
20GPinkStandard adult — elderly/difficult veins
22GBluePaediatrics, elderly with thin fragile veins
24GYellowNeonates, very fragile veins
Equipment Required
  • Tourniquet
  • 70% isopropyl alcohol swab
  • Appropriate gauge cannula
  • Transparent semi-permeable dressing
  • 10 mL 0.9% NaCl flush (pre-drawn)
  • 10 mL syringe
  • Non-sterile gloves
  • Sharps bin (at point of care)
  • Date/time label for documentation
Insertion Technique — Step by Step
  1. Explain procedure and gain verbal consent. Position patient comfortably with arm supported.
  2. Apply tourniquet 5–10 cm above chosen site. Ask patient to clench fist if needed.
  3. Palpate and visualise vein — assess direction, depth, and mobility.
  4. Clean skin with 70% isopropyl alcohol swab — 30 seconds friction, allow 30 seconds to dry completely (do not fan or blow).
  5. Apply skin traction distally with non-dominant hand to stabilise vein.
  6. Insert cannula bevel up at 15–30° to skin in the direction of blood flow.
  7. Observe for blood flashback in the chamber — advance needle 2–3 mm further into vessel.
  8. Lower angle slightly, advance cannula off needle into vein (slide plastic cannula only).
  9. Release tourniquet. Occlude vein proximally. Remove needle and discard directly into sharps bin.
  10. Connect bung/port. Flush with 10 mL 0.9% NaCl using push-pause technique — check for patency, no swelling, no pain.
  11. Apply transparent dressing. Secure with tape if needed. Label with date, time, gauge, and name.
  12. Document fully in patient record.
Push-pause flush technique: Creates turbulence that clears the cannula lumen and prevents fibrin build-up. Always end on positive pressure (clamp while still flushing).
Difficult IV Access Strategies
  • Apply warm towels or warm packs to limb for 5–10 minutes to dilate veins
  • Allow gravity — dangle arm dependent for 1–2 minutes
  • Ask patient to clench/release fist repeatedly
  • Transillumination device if available
  • Ultrasound-guided cannulation (UGIV) — requires trained practitioner
  • Consider intraosseous (IO) access in emergency if IV access fails rapidly
  • Consider PICC/midline for longer-term difficult access
VIP Score — Visual Infusion Phlebitis Scale

Maddox VIP Score — assess daily at every shift. Remove cannula at score ≥2.

0
No symptoms — IV site appears healthy
1
Slight pain near IV site OR slight redness
2
Two of: pain, erythema, swelling — re-site cannula
3
All of: pain, erythema, swelling — re-site; consider treatment
4
Purulent exudate — re-site; treat infection
5
Thrombophlebitis — initiate treatment; re-site urgently
Routine cannula change: every 72–96 hours per hospital policy (or sooner if VIP ≥2 or clinically indicated).
Complications
ComplicationSignsAction
PhlebitisErythema, warmth, cord-like vein, pain along tractRemove cannula, apply warm compress, document, re-site proximally
InfiltrationSwelling, coolness, pallor around site, slow/stopped infusionStop infusion immediately, remove cannula, elevate limb, assess extent
ExtravasationAs infiltration but with vesicant drug — blistering, tissue damageStop immediately, do not remove cannula — aspirate residual drug first; follow vesicant protocol; involve pharmacy/senior
HaematomaBruising/swelling at site on insertion or post-removalApply firm pressure ≥2 min (longer if anticoagulated), elevate limb
Infection / CRBSIPurulent discharge, fever, localised erythema, systemic sepsisRemove cannula, send tip for MC&S, blood cultures, escalate
Nerve injurySharp shooting pain, paraesthesia, inability to move fingersRemove cannula immediately, document, escalate, incident report
Documentation Requirements
Document: Date & time of insertion | Site (right/left, specific vein) | Gauge | Number of attempts | Who inserted | Flush confirmed patent | Next review date. Record VIP score at each assessment shift.

Nasogastric Tube Insertion & Management

Indications
  • Enteral nutrition (short-term feeding)
  • Medication delivery when oral route unavailable
  • Gastric decompression (bowel obstruction, post-operative ileus)
  • Drug overdose — gastric lavage (selected cases)
  • Specimen collection (gastric contents)
Contraindications / High-Risk Situations
  • Base of skull fracture — use orogastric tube (OGT) only
  • Raised intracranial pressure — use OGT; avoid nasal stimulation
  • Coagulopathy — proceed with caution; gel liberally
  • Oesophageal varices / recent oesophageal surgery — senior-led decision
NEX Measurement

Estimate insertion length before insertion using the NEX method:

Nose → Earlobe → Xiphisternum
Measure this distance on the tube and mark it with tape or note the marking. Advance a further 10 cm past the NEX measurement to ensure gastric placement.

Typical adult insertion length: 50–60 cm (varies by patient height).

Tube Sizing
  • Fine-bore feeding tube: 8–12 Fr (preferred for nutrition — less discomfort)
  • Wide-bore (Ryles): 12–16 Fr (decompression, lavage, large volumes)
Insertion Technique
  1. Explain procedure and gain consent. Position patient upright at 45–90° (high Fowler's). Have tissues and emesis basin available.
  2. Check nostrils — select most patent side. Assess for obstruction, previous trauma, or surgery.
  3. Measure NEX distance on the tube and mark/note the measurement. Add 10 cm.
  4. Apply water-soluble lubricant / anaesthetic gel (lignocaine gel if prescribed) to tip of tube.
  5. Insert tube horizontally into nostril (not upward) — advance along floor of nasal cavity.
  6. As tube reaches posterior pharynx (~15 cm), ask patient to flex chin to chest and swallow water through a straw if able — this opens the oesophagus and closes the trachea.
  7. Advance tube with each swallow. If resistance, coughing, or gagging persists — withdraw slightly and retry. Do NOT force.
  8. Continue advancing to marked measurement (NEX + 10 cm).
  9. Temporarily secure tube to nose with tape. Confirm position before proceeding.
Position Confirmation — Safety Critical
NEVER use the whoosh/auscultation test ("air bubbling" test) — this method is unreliable and has caused fatal misplacements. It is banned in evidence-based practice and must not be used as a sole confirmation method.
pH Testing — Gold Standard (1st Line)

Aspirate gastric contents using a syringe. Test aspirate with CE-marked pH indicator paper.

pH ≤5.5 = gastric position confirmed — safe to use.
pH 5.5–6 = inconclusive — proceed to X-ray.
pH >6 = do NOT use — X-ray required.
  • Check placement before every feed and every medication dose
  • If unable to aspirate: reposition patient (roll to side), advance 5 cm, try again
  • pH may be falsely elevated if patient on PPI/H2 antagonist — X-ray if doubt
X-Ray Confirmation — Required in High-Risk Cases

Request chest/abdominal X-ray when:

  • pH is indeterminate (5.5–6)
  • Unable to aspirate at all after repositioning
  • High-risk patient: diminished cough/gag, sedated, ICU, neurological impairment
  • Fine-bore tube — more prone to coiling
  • Initial placement in any unconscious/intubated patient
X-ray: tube tip should be clearly below the diaphragm and to the left of midline (gastric). Any doubt — do not use; seek radiologist review.
NEVER flush or feed through the tube before position is confirmed. Pulmonary aspiration of feed is a serious, potentially fatal complication.
Securing the Tube
  • Use hypoallergenic tape or nasal NG fixator device
  • Nasal loop technique: loop tape around tube then fix to nose/cheek
  • Avoid tension — prevents pressure injury to nares
  • Mark tube at nostril level with permanent marker — document external length
  • Re-confirm position if external length changes or tube appears displaced
NG Feed Complications
  • Aspiration: Maintain HOB ≥30° during feeding; check gastric residual volumes per policy; pause feed if residual >200–500 mL (per local protocol)
  • Diarrhoea: Review feed rate, osmolality, antibiotic use, C. diff
  • Tube displacement: Check external length, reconfirm placement — never just re-advance without confirmation
  • Nasal/pharyngeal ulceration: Regular nares inspection, rotate nostril if long-term
  • Refeeding syndrome: Monitor electrolytes (PO4, K, Mg) — especially after prolonged starvation

Urinary Catheterisation

Catheter Types
TypeUse
Foley 2-wayStandard urinary drainage — retention/monitoring
Foley 3-wayPost-TURP, haematuria — continuous bladder irrigation
Tiemann-tipEnlarged prostate — curved tip aids passage
SuprapubicLong-term, urethral obstruction, post-pelvic surgery — inserted by physician
IntermittentNeurogenic bladder, CISC programme
Sizing
  • Male standard: 12–14 Fr (haematuria: 16–18 Fr, 3-way 20–22 Fr)
  • Female standard: 10–14 Fr
  • Balloon volume: 10 mL sterile water (standard adult); 30 mL for traction post-TURP
Male Catheterisation — Anatomy & Technique
Urethra length ~18–20 cm. Key anatomical points: navicular fossa, penile urethra, bulbomembranous urethra (external sphincter — point of resistance), prostatic urethra, internal sphincter (smooth muscle), bladder neck.
  1. ANTT throughout. Open sterile field. Prepare equipment.
  2. Retract foreskin (if present) — must be restored after procedure to prevent paraphimosis.
  3. Clean glans/meatus with 0.9% NaCl using non-touch technique.
  4. Insert 2% lignocaine gel (instillagel) into urethra — wait minimum 5 minutes for anaesthetic effect.
  5. Apply gentle upward traction (perpendicular to body) to straighten penile urethra.
  6. Advance catheter slowly — do not force. At bulbomembranous urethra (resistance point), ask patient to breathe deeply / bear down gently.
  7. At prostatic urethra — angle catheter downward toward patient's feet.
  8. Advance until urine drains (advance further 2–3 cm before inflating balloon).
  9. Inflate balloon with 10 mL sterile water. Withdraw catheter until resistance felt.
  10. Connect to closed drainage bag. Restore foreskin. Secure catheter to thigh.
Female Catheterisation
Female urethra: ~4 cm long. Urethral meatus located anterior to vaginal opening (posterior to clitoris). Identification can be difficult — use adequate lighting, consider patient positioning (frog-leg / lithotomy).
Technique
  1. Position patient supine with knees bent and abducted (frog-leg).
  2. ANTT. Open sterile field.
  3. Clean labia minora and urethral meatus with 0.9% NaCl — always front to back.
  4. Apply lignocaine gel if indicated / per local policy.
  5. Identify urethral meatus — if unsure, use a gloved finger to gently separate labia. Do not insert into vagina.
  6. Advance catheter ~5–6 cm until urine drains. Advance 2–3 cm further.
  7. Inflate balloon with 10 mL sterile water. Connect drainage. Secure.
Identification Tips
  • Urethral meatus is smaller, round, anterior
  • Vaginal opening is larger, posterior — if catheter enters vagina, leave it in place as a landmark and insert new catheter anteriorly
  • Elderly/post-menopausal: atrophic changes may obscure anatomy — use extra lighting
  • If insertion into vagina is suspected — no urine drainage; check positioning
If catheter accidentally placed in vagina: leave in place as anatomical landmark, insert new sterile catheter into urethra, then remove vaginal catheter.
Difficult Catheterisation
If unable to advance catheter — STOP. Do not force. Forced catheterisation causes urethral trauma, false passages, and bleeding.
  • Call for experienced help immediately — senior nurse or urology team
  • Consider Tiemann-tip catheter for BPH/stricture
  • Urology referral for flexible cystoscopy-guided catheterisation
  • Suprapubic catheterisation by physician if urethral route impossible
CAUTI Prevention
Daily Indication Review

Ask every day: Is this catheter still clinically necessary? Remove as soon as indication is resolved.

  • Maintain closed drainage system — never break circuit unnecessarily
  • Hand hygiene before and after any handling of catheter/bag
  • Keep drainage bag below bladder level at all times (prevent backflow)
  • Catheter care BD: clean perineum/meatus with soap and water
  • Avoid unnecessary sampling — use needle-free port with ANTT
  • Document output, catheter size, balloon volume, insertion date every shift
Catheter Removal & TWOC
  • Deflate balloon fully using 10 mL syringe before removal
  • Remove gently — do not cut drainage bag tubing
  • TWOC (Trial Without Catheter): document time of removal, first void time and volume
  • Post-void residual (PVR): bladder scan 30 min after first void — PVR >300 mL (or per policy) may indicate need for re-catheterisation
  • Encourage fluids post-removal
Catheter Maintenance Solutions
Optiflo G (Suby G solution): Citric acid 3.23% — pH 4. Used for catheter encrustation (crystalline blockage). Dissolves struvite/phosphate crystals. Use per policy — typically 50 mL instilled, retained 30 min, then drain.

Optiflo R (Solution R): 6% citric acid — for more resistant encrustations. Consult urology before use.

Not for routine flushing — only indicated when catheter is blocked or encrusted.

Blood Glucose Monitoring & Insulin Administration

Capillary Blood Glucose (BM) Monitoring
  1. Check glucometer QC is current (within range). Check strip expiry date and calibration code matches meter.
  2. Wash and dry patient's hand — do not use alcohol swab (falsely elevated result).
  3. Use lancet on the lateral side of fingertip (less painful) or palm — avoid index finger/thumb (used for grip).
  4. Obtain a free-flowing drop — do not squeeze excessively (dilutes sample with tissue fluid).
  5. Apply blood to test strip per manufacturer instructions. Read result.
  6. Apply gentle pressure to puncture site.
  7. Document result with time, site, patient ID, and any action taken.
POCT (Point-of-Care Testing) Requirements (JCI/HAAD/DHA): Daily QC documentation, external QC reagents (high and low), competency records for all staff performing POCT, calibration records, equipment maintenance log.
Insulin Types — Quick Reference
TypeExamplesOnset / Duration
Rapid-actingNovoRapid, Humalog, ApidraOnset 10–20 min / Duration 3–5 h
Short-actingActrapid, Humulin ROnset 30–60 min / Duration 6–8 h
IntermediateInsulatard, Humulin N (NPH)Onset 1–2 h / Duration 12–18 h
Long-actingLantus (glargine), Levemir (detemir), Tresiba (degludec)Onset 1–4 h / Duration 20–42 h — no peak
PremixedNovoMix 30, Humulin M3Biphasic — varies by ratio
Subcutaneous Insulin Injection Technique
Insulin Pen Technique
  1. Check insulin type, dose, expiry, appearance (clear or cloudy as expected). Roll intermediate/premixed gently (do not shake).
  2. Attach new pen needle (4 mm preferred — reduces intramuscular risk).
  3. Prime 2 units with needle pointing up — confirms needle patency, removes air.
  4. Dial required dose. Double-check with second nurse (high-alert medication).
  5. Select injection site — abdomen preferred (fastest absorption), thigh, upper arm, or buttock.
  6. Pinch skin if patient is thin or using short needle. Insert needle at 90° (45° if very thin).
  7. Depress plunger fully. Hold for 10 seconds before removing needle — prevents dose loss.
  8. Remove needle. Do not recap — discard in sharps bin.
  9. Apply gentle pressure — do not rub (may accelerate absorption).
  10. Document dose, site, time, BM result.
Site Rotation
Rotate injection sites systematically to prevent lipohypertrophy (fatty lumps from repeated injections at same site). Lipohypertrophic tissue has erratic/reduced absorption — can cause glycaemic variability.
Absorption Rate by Site
  • Abdomen: fastest (preferred for mealtime insulin)
  • Upper arm: intermediate
  • Thigh: slower (good for basal insulin)
  • Buttock: slowest
IV Insulin Infusion
Only regular/soluble insulin (e.g. Actrapid, Humulin R) may be given intravenously. Insulin analogues (NovoRapid, Lantus, etc.) must NOT be given IV — not licensed for IV use.
  • Dedicated IV line for insulin infusion — do not piggyback other medications
  • Standard concentration: 1 unit/mL (50 units in 50 mL 0.9% NaCl via syringe driver)
  • Flush line with insulin solution before starting — insulin adsorbs to plastic tubing
  • Hourly BM monitoring (or as per VRIII/sliding scale protocol)
  • VRIII (Variable Rate Intravenous Insulin Infusion): used peri-operatively and for DKA/HHS management alongside glucose/potassium infusion
  • Potassium monitoring essential — insulin drives K+ intracellularly
Hypoglycaemia Management
Definition: Capillary BG <4.0 mmol/L
Conscious Patient — Oral Treatment

Give 15–20 g fast-acting carbohydrate:

  • 150–200 mL fruit juice or regular (non-diet) fizzy drink
  • 5–6 glucose tablets (GlucoTabs)
  • 3–4 teaspoons of sugar dissolved in water
  • Glucogel (40% glucose gel) — 1–2 tubes buccally

Recheck BG after 15 minutes. If still <4 mmol/L — repeat. Once BG ≥4, give long-acting carbohydrate (biscuits, bread).

Unconscious / Unable to Swallow
  • IV: 75–80 mL of 20% glucose (or 150 mL 10% glucose) — IV access required
  • IM/SC: Glucagon 1 mg — if no IV access available
  • Recheck BG 10–15 minutes after IV treatment
  • Identify and treat cause — missed meal, excess insulin, renal impairment
Insulin — High-Alert Medication Rules
Insulin is a HIGH-ALERT medication — errors have caused patient deaths. The following safeguards are mandatory in GCC hospitals (JCI/HAAD/DHA standards):
Double-Check Required
  • Two registered nurses must independently check: drug name, type, dose, device, route, patient ID
  • Verify against medication chart — both sign
  • Never abbreviate "units" as "U" (confused with zero) — write "units" in full
Storage & Labelling
  • Store unopened vials/pens in refrigerator (2–8°C)
  • In-use pens: room temperature for up to 28 days (product-specific)
  • Label all insulin syringes prepared for IV use — "INSULIN" in capitals
  • Never transfer between insulin pens
Administration Errors Prevention
  • Use insulin-specific syringes (units marked) — never standard syringe
  • Confirm patient has eaten (or will eat) before mealtime insulin
  • Hold insulin if patient NBM — contact prescriber
  • Report all insulin errors immediately — patient safety incident

Wound Care & Dressing Competencies

ANTT — Aseptic Non-Touch Technique
ANTT Principle: Identify KEY PARTS (parts that must remain sterile — e.g. wound surface, sterile field, needle tip, syringe tip, catheter tip) and KEY SITES (patient's wound/access point). Never touch these directly.
Standard ANTT (Ward Procedures)
  • Non-sterile gloves acceptable for wound dressings with a critical micro aseptic field
  • Sterile field maintained within a general aseptic field
  • Non-touch technique used throughout
  • Applicable to: cannulation, simple wound dressings, urinary catheterisation
Surgical ANTT (Theatre/Complex Procedures)
  • Sterile gloves required
  • Larger critical aseptic field
  • Used for: CVC insertion, complex wound management, chest drain insertion
Key ANTT exam point: The critical concept is "non-touch of key parts" — this is what differentiates ANTT from general clean technique.
WHO 5 Moments of Hand Hygiene
#Moment
1Before patient contact
2Before aseptic procedure / clean/aseptic task
3After body fluid exposure risk
4After patient contact
5After contact with patient environment/surroundings
Moment 2 is the most critical for wound care and any aseptic procedure. Hand hygiene with ABHR (alcohol-based hand rub) takes 20–30 seconds. Hand washing with soap and water: 40–60 seconds — required for C. diff, norovirus (alcohol-resistant spores).
Wound Assessment — MEASURE Framework
  • Measure: length × width × depth (cm)
  • Exudate: volume (none/light/moderate/heavy), colour, odour, consistency
  • Appearance of wound bed: % granulation, slough, necrosis, epithelialisation
  • Surrounding skin: maceration, erythema, excoriation, oedema, warmth
  • Undermining/tunnelling: probe depth (cm), clock positions
  • Re-evaluate: compare with previous assessment — healing or deteriorating?
  • Edge of wound: well-defined, rolled, undermined, macerated, callused
  • Infection signs: erythema, warmth, oedema, purulent exudate, odour, pain — escalate and consider wound swab for MC&S
Dressing Selection Algorithm
Wound TypeCharacteristicsDressing Choice
Dry / EscharHard black/brown necrotic tissue, minimal exudateHydrogel (rehydrates to aid autolytic debridement) ± occlusive film
SloughyYellow/grey necrotic tissue, moderate exudateHydrofibre (e.g. Aquacel) or Alginate — absorbs and promotes autolytic debridement
GranulatingRed/pink granulation tissue, variable exudateFoam dressing (e.g. Mepilex) — moist wound healing, absorbent
InfectedSigns of infection, biofilm, odourAntimicrobial: silver (e.g. Aquacel Ag), cadexomer iodine (Iodosorb) — use for 2 weeks then reassess
High exudateHeavy exudate, at risk of macerationAlginate (highly absorbent) + foam secondary dressing
EpithelialisingPink skin growing from wound edges, near-healedLow-adherent non-stick dressing (e.g. Mepitel One, Adaptic)
Tracheostomy Care
Emergency equipment at bedside at ALL TIMES: Spare tracheostomy tube (same size + one size smaller), tracheal dilators, 10 mL syringe, suction equipment, bag-valve-mask.
Inner Tube Management
  • Non-disposable inner tube: Remove, clean with 0.9% NaCl and brush, dry, reinsert — minimum q4h or as per secretion levels
  • Disposable inner tube: Remove and replace with new tube — q4h or per protocol
  • Never leave tracheostomy without inner tube for more than 10–15 seconds
Tie Change — Two-Person Technique
  • Two nurses always required for tie change — one holds tube while second changes ties
  • Check ties are secure: one finger breadth space under ties
  • Assess stoma site for skin breakdown, granulation, infection
CVC Dressing Care & PEG Site Care
CVC Dressing Change
  • Transparent semi-permeable dressing: change every 7 days or when soiled/loose/lifting
  • Chlorhexidine-impregnated dressing (e.g. Biopatch/Tegaderm CHG): preferred at insertion site
  • "Scrub the hub": Before any access — clean needleless connector with 70% isopropyl alcohol for 15 seconds; allow to dry before accessing
  • Document dressing date, insertion site condition, any signs of infection
PEG Site Care
  • Clean site daily with soap and water — dry thoroughly
  • Rotate external disc/bumper 360° daily to prevent buried bumper syndrome
  • Check tube length/external position at each use
  • Assess for overgranulation (hypergranulation tissue) — manage with silver nitrate sticks or corticosteroid cream per specialist advice
  • Ensure tube moves freely 1–2 cm within stoma — if fixed, report

GCC Exam Focus & Quick Reference

High-Yield Exam Topics
These topics appear frequently in DHA, DOH, HAAD, SCFHS, and QCHP nursing examinations. Review each section carefully — safety-critical items are exam priorities.
VIP Score — Complete Scale (0–5)
ScoreObservationAction
0IV site appears healthy — no signsContinue monitoring
1One of: slight pain near site OR slight rednessObserve — document
2Two of: pain, erythema, swellingRe-site cannula
3All of: pain, erythema, swelling; IV site streakingRe-site; consider treatment
4Purulent discharge at siteRe-site; treat infection; incident report
5Visible thrombophlebitis; induration; palpable cordInitiate treatment; re-site urgently; senior review
Exam point: Remove cannula at VIP score of 2 or above. Do NOT wait for score of 3 or 4.
NG Tube Position Confirmation — Exam Safety Rules
MethodReliabilityGCC Exam Verdict
pH testing (aspirate pH ≤5.5)High — gold standard 1st lineCORRECT — use first
X-ray (chest/abdominal)High — definitiveCORRECT — required when pH inconclusive or high-risk
Air auscultation ("whoosh test")Unreliable — cannot distinguish gastric from bronchial placementNEVER acceptable — banned practice
Capnography (CO2 detection)High — confirms absence of bronchial placementAdjunct — not universally available
Exam answer: If asked "which method should NOT be used to confirm NG tube placement?" — answer: Auscultation / whoosh test.
NEVER flush before position confirmed — this is a NPSA safety alert and exam-critical fact.
Insulin High-Alert Rules — Exam Summary
ANTT Key Principles — Exam Summary
  • Key parts: parts that if contaminated, risk infection — needle tip, syringe tip, wound surface, catheter tip, sterile field
  • Key sites: patient access points — wounds, IV insertion sites, catheter entry
  • Never touch key parts — this is the defining rule of ANTT
  • Standard ANTT: non-sterile gloves + critical micro aseptic field
  • Surgical ANTT: sterile gloves + full sterile field
Common exam question: A nurse is about to do a wound dressing. She touches the sterile gauze with an ungloved hand. This is a failure of which principle?

Answer: Non-touch of key parts (ANTT breach)
ANTT does NOT mean the nurse is sterile — it means the KEY PARTS remain uncontaminated through non-touch technique.
DHA / DOH / SCFHS / QCHP High-Yield Clinical Skills Questions
Question TypeKey Answer
First-line NG tube confirmation methodpH testing — pH ≤5.5 confirms gastric position
Method NEVER used for NG confirmationAuscultation / whoosh test
VIP score at which to remove IV cannulaScore 2 or above
Catheter balloon inflation volume (adult)10 mL sterile water
Insulin that can be given IVRegular/soluble insulin only (e.g. Actrapid)
Hypoglycaemia definitionBG <4.0 mmol/L
NEX measurement stands forNose – Earlobe – Xiphisternum
Insulin pen — seconds to hold after injection10 seconds
ANTT key conceptNon-touch of key parts
Cannula gauge for blood transfusion16G (or 18G minimum)
CAUTI prevention — most important interventionDaily review of catheter necessity / early removal
CVC hub cleaning time"Scrub the hub" — 15 seconds with 70% isopropyl alcohol
Two-person technique required forTracheostomy tie change
PEG site — daily action to prevent buried bumperRotate external disc 360°
IV insulin — dedicated line ruleYes — never piggyback other medications on insulin line

Clinical Skills Competency Self-Assessment Tracker

Rate your self-assessed competency level for each skill. 1 = Never done  |  2 = Observed only  |  3 = Assisted  |  4 = Done with supervision  |  5 = Independent practice

0/20
Skills at independent level (5)
Overall Competency Progress
0% average competency
0
Skills ready for independent practice
Complete the assessment above to see your readiness summary.
`); w.document.close(); w.print(); } function showTab(id) { document.querySelectorAll('.tab-content').forEach(t => t.classList.remove('active')); document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active')); document.getElementById('tab-' + id).classList.add('active'); event.currentTarget.classList.add('active'); } function toggleAcc(el) { el.classList.toggle('open'); const body = el.nextElementSibling; body.classList.toggle('open'); } buildTracker();